BriaCell Therapeutics Reports Fiscal 2026 Net Loss of $35.3 Million
BriaCell Therapeutics reported a $35.3 million net loss for fiscal 2026, compared with a $26.6 million net loss in fiscal 2025. Research and development and clinical-trial expenses increased.
BriaCell Therapeutics Corp. reported a net loss of $35.3 million for fiscal 2026, compared with a $26.6 million net loss in fiscal 2025, as research and development and clinical-trial expenses increased.Financial HighlightsBusiness HighlightsOriginal SEC Filing: BriaCell Therapeutics Corp. [ BCTX…